Earnings Beat, Higher Dividend And New CFO Might Change The Case For Investing In Regis (ASX:REG)

Simply Wall St.08-27

Regis Healthcare Limited (ASX:REG) recently reported full-year 2026 results showing revenue of A$1.54 billion and net income of A$55.69 million, announced a fully franked final dividend of A$0.094 per...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2662294744?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","is_english":true,"pubTime":"2026-08-27 01:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662294744","market":"sg","top_or_hot":-1,"title":"Earnings Beat, Higher Dividend And New CFO Might Change The Case For Investing In Regis (ASX:REG)","media":"Simply Wall St.","content":"<div>\n<p>Regis Healthcare Limited (ASX:REG) recently reported full-year 2026 results showing revenue of A$1.54 billion and net income of A$55.69 million, announced a fully franked final dividend of A$0.094 per...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/earnings-beat-higher-dividend-and-new-cfo-might-change-the-c\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Earnings Beat, Higher Dividend And New CFO Might Change The Case For Investing In Regis (ASX:REG)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEarnings Beat, Higher Dividend And New CFO Might Change The Case For Investing In Regis (ASX:REG)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-27 01:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/earnings-beat-higher-dividend-and-new-cfo-might-change-the-c><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regis Healthcare Limited (ASX:REG) recently reported full-year 2026 results showing revenue of A$1.54 billion and net income of A$55.69 million, announced a fully franked final dividend of A$0.094 per...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/earnings-beat-higher-dividend-and-new-cfo-might-change-the-c\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REG","symbol_name":"Regency Centers Corp","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/earnings-beat-higher-dividend-and-new-cfo-might-change-the-c","article_id":"2662294744","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/earnings-beat-higher-dividend-and-new-cfo-might-change-the-c","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2662294744","pubTimestamp":1787765492,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Regis Healthcare Limited (ASX:REG) recently reported full-year 2026 results showing revenue of A$1.54 billion and net income of A$55.69 million, announced a fully franked final dividend of A$0.094 per share, outlined an acquisition-focused growth agenda, and confirmed a CFO transition to Stuart Hooper.\nThe combination of earnings growth, a higher dividend and an active M&A pipeline, supported by a new CFO with deep healthcare experience, signals management’s focus on scaling the business...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"REG":"Regency Centers Corp","REG.AU":"REGIS HEALTHCARE LTD"},"translate_title":"盈利超出预期、更高的股息和新任首席财务官可能会改变投资 Regis (ASX:REG) 的情况","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REG.AU":1.5,"REG":1.5},"content_text":"Regis Healthcare Limited (ASX:REG) recently reported full-year 2026 results showing revenue of A$1.54 billion and net income of A$55.69 million, announced a fully franked final dividend of A$0.094 per share, outlined an acquisition-focused growth agenda, and confirmed a CFO transition to Stuart Hooper. The combination of earnings growth, a higher dividend and an active M&A pipeline, supported by a new CFO with deep healthcare experience, signals management’s focus on scaling the business while maintaining financial discipline. We’ll now examine how Regis’s earnings growth and increased dividend influence its existing investment narrative and future growth assumptions. The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.AdvertisementRegis Healthcare Investment Narrative RecapTo own Regis Healthcare, you need to believe that long term demand for aged care and ongoing sector reforms can support sustainable earnings and dividends, despite tight funding settings and rising staff costs. The FY2026 result and higher fully franked dividend support the near term earnings and cash generation story, while the most immediate risk remains cost inflation and funding indexation that may not fully cover mandated care minutes and workforce pressures. Overall, this news does not fundamentally alter the short term catalyst or the biggest risk. The FY2026 dividend increase to A$0.094 per share stands out in the latest announcements, because it directly connects earnings outcomes with shareholder returns. For investors watching near term catalysts, a higher dividend signals that management is comfortable returning more cash while also pursuing an active acquisition pipeline, even as sector wide wage, care minute and policy risks continue to sit in the background. Yet alongside this higher dividend, investors should be aware that rising wage costs and mandated care minutes could still... Read the full narrative on Regis Healthcare (it's free!)Regis Healthcare's narrative projects A$1.7 billion revenue and A$88.7 million earnings by 2029. This requires 10.2% yearly revenue growth and an A$50.7 million earnings increase from A$38.0 million today.Uncover how Regis Healthcare's forecasts yield a A$7.79 fair value, a 27% upside to its current price.Exploring Other PerspectivesASX:REG 1-Year Stock Price Chart Three Simply Wall St Community fair value estimates for Regis range from A$7.26 to A$15.61, underlining how far apart individual views can be. When you set that against the current focus on acquisitions and sector funding risks, it becomes clear why checking several independent opinions on Regis’s earnings resilience and growth assumptions matters.Explore 3 other fair value estimates on Regis Healthcare - why the stock might be worth just A$7.26!Decide For YourselfDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Regis Healthcare research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.Our free Regis Healthcare research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Regis Healthcare's overall financial health at a glance.Looking For Alternative Opportunities?Every day counts. These free picks are already gaining attention. See them before the crowd does:This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.Find 13 companies with promising cash flow potential yet trading below their fair value.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2662294744","isCrawlerRequest":true}